| Original language | English |
|---|---|
| Pages (from-to) | 38-48 |
| Number of pages | 11 |
| Journal | Transplant International |
| Volume | 32 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2019 |
Keywords
- anti-humoral therapy
- antibody-mediated rejection
- complement-binding DSA
- de novo donor-specific anti-HLA antibodies
- pediatric kidney transplantation
- complement component C1q
- complement component C3d
- HLA antibody
- immunoglobulin
- rituximab
- tacrolimus
- alloantibody
- antibody
- HLA antigen
- antibody mediated rejection
- Article
- child
- clinical article
- clinical outcome
- controlled study
- disease association
- drug megadose
- drug resistance
- estimated glomerular filtration rate
- female
- fluorescence analysis
- follow up
- graft failure
- graft recipient
- human
- human cell
- human tissue
- kidney function
- kidney graft rejection
- kidney transplantation
- low drug dose
- male
- plasmapheresis
- prediction
- priority journal
- prognosis
- protein binding
- retrospective study
- risk assessment
- treatment failure
- treatment outcome
- adolescent
- biopsy
- donor
- graft rejection
- graft survival
- immunology
- kidney
- multivariate analysis
- risk
- Adolescent
- Antibodies
- Biopsy
- Child
- Female
- Follow-Up Studies
- Graft Rejection
- Graft Survival
- HLA Antigens
- Humans
- Isoantibodies
- Kidney
- Kidney Transplantation
- Male
- Multivariate Analysis
- Prognosis
- Retrospective Studies
- Risk
- Rituximab
- Tissue Donors
Cite this
Failure to remove de novo donor-specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody-mediated rejection destined to graft loss – a retrospective study. / Cioni, M.; Nocera, A.; Tagliamacco, A.; Basso, S.; Innocente, A.; Fontana, I.; Magnasco, A.; Trivelli, A.; Klersy, C.; Gurrado, A.; Ramondetta, M.; Boghen, S.; Catenacci, L.; Verrina, E.; Garibotto, G.; Ghiggeri, G.M.; Cardillo, M.; Ginevri, F.; Comoli, P.
In: Transplant International, Vol. 32, No. 1, 2019, p. 38-48.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Failure to remove de novo donor-specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody-mediated rejection destined to graft loss – a retrospective study
AU - Cioni, M.
AU - Nocera, A.
AU - Tagliamacco, A.
AU - Basso, S.
AU - Innocente, A.
AU - Fontana, I.
AU - Magnasco, A.
AU - Trivelli, A.
AU - Klersy, C.
AU - Gurrado, A.
AU - Ramondetta, M.
AU - Boghen, S.
AU - Catenacci, L.
AU - Verrina, E.
AU - Garibotto, G.
AU - Ghiggeri, G.M.
AU - Cardillo, M.
AU - Ginevri, F.
AU - Comoli, P.
N1 - Export Date: 28 August 2019 CODEN: TRINE Correspondence Address: Ginevri, F.; Nephrology, Dialysis, Transplantation Unit, IRCCS Istituto Giannina GasliniItaly; email: fabrizioginevri@gaslini.org
PY - 2019
Y1 - 2019
KW - anti-humoral therapy
KW - antibody-mediated rejection
KW - complement-binding DSA
KW - de novo donor-specific anti-HLA antibodies
KW - pediatric kidney transplantation
KW - complement component C1q
KW - complement component C3d
KW - HLA antibody
KW - immunoglobulin
KW - rituximab
KW - tacrolimus
KW - alloantibody
KW - antibody
KW - HLA antigen
KW - antibody mediated rejection
KW - Article
KW - child
KW - clinical article
KW - clinical outcome
KW - controlled study
KW - disease association
KW - drug megadose
KW - drug resistance
KW - estimated glomerular filtration rate
KW - female
KW - fluorescence analysis
KW - follow up
KW - graft failure
KW - graft recipient
KW - human
KW - human cell
KW - human tissue
KW - kidney function
KW - kidney graft rejection
KW - kidney transplantation
KW - low drug dose
KW - male
KW - plasmapheresis
KW - prediction
KW - priority journal
KW - prognosis
KW - protein binding
KW - retrospective study
KW - risk assessment
KW - treatment failure
KW - treatment outcome
KW - adolescent
KW - biopsy
KW - donor
KW - graft rejection
KW - graft survival
KW - immunology
KW - kidney
KW - multivariate analysis
KW - risk
KW - Adolescent
KW - Antibodies
KW - Biopsy
KW - Child
KW - Female
KW - Follow-Up Studies
KW - Graft Rejection
KW - Graft Survival
KW - HLA Antigens
KW - Humans
KW - Isoantibodies
KW - Kidney
KW - Kidney Transplantation
KW - Male
KW - Multivariate Analysis
KW - Prognosis
KW - Retrospective Studies
KW - Risk
KW - Rituximab
KW - Tissue Donors
U2 - 10.1111/tri.13325
DO - 10.1111/tri.13325
M3 - Article
VL - 32
SP - 38
EP - 48
JO - Transplant International
JF - Transplant International
SN - 0934-0874
IS - 1
ER -